Allarity Therapeutics, Inc. (ALLR) DCF Valuation

Allarity Therapeutics, Inc. (ALLR) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Allarity Therapeutics, Inc. (ALLR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Engineered for accuracy, our (ALLR) DCF Calculator empowers you to evaluate Allarity Therapeutics, Inc. valuation using real-time financial information and complete flexibility to modify crucial parameters for enhanced forecasting.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .1 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -100 0 0 0 -25 -25 -25 -25 -25
EBITDA -15.6 -6.0 -25.9 -17.2 -12.1 .0 .0 .0 .0 .0
EBITDA, % -12983.33 100 100 100 100 60 60 60 60 60
Depreciation .1 .1 .1 .1 .0 .0 .0 .0 .0 .0
Depreciation, % 70.83 100 100 100 100 94.17 94.17 94.17 94.17 94.17
EBIT -15.7 -6.1 -26.0 -17.4 -12.1 .0 .0 .0 .0 .0
EBIT, % -13054.17 100 100 100 100 60 60 60 60 60
Total Cash 1.5 .3 19.6 2.0 .2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.7 1.1 1.3 .9 .9
Account Receivables, % 1381.67 100 100 100 100
Inventories .0 .0 -1.3 .0 .0 .0 .0 .0 .0 .0
Inventories, % -1.67 100 100 100 100 79.67 79.67 79.67 79.67 79.67
Accounts Payable 2.2 2.1 .7 6.3 8.4 .0 .0 .0 .0 .0
Accounts Payable, % 1815 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -6.67 100 100 100 100 -1.33 -1.33 -1.33 -1.33 -1.33
Tax Rate, % 5.68 5.68 5.68 5.68 5.68 5.68 5.68 5.68 5.68 5.68
EBITAT -11.9 -4.3 -26.1 -15.9 -11.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -11.3 -3.7 -26.3 -11.1 -9.3 -7.5 .0 .0 .0 .0
WACC, % 5.84 5.84 5.84 5.84 5.84 5.84 5.84 5.84 5.84 5.84
PV UFCF
SUM PV UFCF -7.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -7
Net Debt 1
Equity Value -8
Diluted Shares Outstanding, MM 1,991
Equity Value Per Share 0.00

What You Will Get

  • Real ALLR Financial Data: Pre-filled with Allarity Therapeutics' historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Allarity Therapeutics' intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Accurate Financial Data: Gain access to reliable historical performance and future estimates for Allarity Therapeutics, Inc. (ALLR).
  • Tailored Forecast Inputs: Modify highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
  • Real-Time Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Clear and concise charts and summaries to help you interpret your valuation findings.
  • Designed for All Skill Levels: An intuitive format suitable for investors, CFOs, and consultants alike.

How It Works

  • Download: Get the ready-to-use Excel file containing Allarity Therapeutics, Inc.'s (ALLR) financial data.
  • Customize: Modify forecasts, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation findings to inform your investment approach.

Why Choose Allarity Therapeutics, Inc. (ALLR) Calculator?

  • Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for Allarity Therapeutics.
  • Customizable Inputs: Modify yellow-highlighted fields to explore different financial scenarios for (ALLR).
  • Detailed Insights: Automatically computes Allarity's intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and consultants focusing on (ALLR).

Who Should Use This Product?

  • Investors: Accurately assess Allarity Therapeutics, Inc.'s (ALLR) fair value before making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Allarity Therapeutics, Inc. (ALLR).
  • Consultants: Easily modify the template for valuation reports tailored to Allarity Therapeutics, Inc. (ALLR) clients.
  • Entrepreneurs: Acquire insights into financial modeling practices used by leading biotech firms like Allarity Therapeutics, Inc. (ALLR).
  • Educators: Employ it as a teaching resource to illustrate valuation techniques relevant to Allarity Therapeutics, Inc. (ALLR).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Allarity Therapeutics historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Allarity Therapeutics, Inc. (ALLR).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

Es wurden keine passenden Produkte gefunden.